home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
Revolution Medicines to Participate in Upcoming Investor Conferences
Revolution Medicines to Participate in Upcoming Investor Conferences
Post navigation
Previous Post
Previous
Kronos Bio Announces Positive End-of-Phase 2 Meeting with FDA for Entospletinib in Newly Diagnosed NPM1-mutated Acute Myeloid Leukemia (AML)
Next Post
Next
Arvinas to Participate in Upcoming Virtual Investor Conferences